United States · Venture startup
Funding summaryUpdated 26 Oct 2026
$92Mraised across 6 rounds since 2002, from 6 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
Reported by sec.govSEC filing: $975K sold, first sale Mar 2012
No investor was named in the report.
Reported by sec.govSEC filing: $3.0M sold, first sale Feb 2012
No investor was named in the report.
Reported by sec.govSEC filing: $20M sold, first sale Jul 2011
ARCH Venture Partners
Alta Partners
Montreux Growth Partners
Global Life Science VenturesFrom a historical funding record
ARCH Venture PartnersAlta PartnersMontreux Growth Partners
Duke UniversityFrom a historical funding record
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
ARCH Venture PartnersWalden InternationalAlta PartnersMontreux Growth PartnersSV Life SciencesGlobal Life Science VenturesMitsubishi Corporation Life Sciences VentureDuke UniversityTIAA-CREFGrove Street AdvisorsFrom historical deal records. Wrong? Tell us.
Missing a round, or an investor who was in one? Tell us.
NeurogesX's investors include ARCH Venture Partners, Walden International, Alta Partners, Montreux Growth Partners and SV Life Sciences, and 5 more on record.
NeurogesX has raised $92M across 6 rounds since 2002.
NeurogesX's most recent round was a Venture of $975K in Mar 2012.
NeurogesX's largest round on record is $25M (Venture), in Jan 2008.
NeurogesX's first round on record, in Jan 2002, was backed by ARCH Venture Partners, Walden International and Alta Partners and 4 others.
NeurogesX's latest named round is a Venture, in Mar 2012.
NeurogesX is based in the United States.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
